Calderon, Gilbert, Jr. .
HRN: 24-06-52 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/05/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
12/05/2024
12/12/2024
PO
4 ML
Q8H
INTESTINAL AMOEBIASIS
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes